Literature DB >> 19956836

Epigenetic silencing of RELN in gastric cancer.

Osamu Dohi1, Hisashi Takada, Naoki Wakabayashi, Kohichiroh Yasui, Chouhei Sakakura, Shoji Mitsufuji, Yuji Naito, Masafumi Taniwaki, Toshikazu Yoshikawa.   

Abstract

RELN (Reelin) is an extracellular glycoprotein that plays a critical role in neuronal migration. Here we show that the RELN gene is frequently silenced in gastric cancers (GCs) by aberrant promoter hypermethylation. Although RELN was strongly expressed in non-tumor gastric epithelia, its expression was weak, or absent, in GC cell lines and primary GC tumors. Absence of RELN expression significantly correlated with a more advanced stage of GC. Methylation of the RELN promoter was frequently found in GC cell lines and in primary GC tumors. These findings suggest that disruption of the RELN pathway may be involved in gastric carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19956836

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  29 in total

1.  miR-200c regulates FGFR-dependent epithelial proliferation via Vldlr during submandibular gland branching morphogenesis.

Authors:  Ivan T Rebustini; Toru Hayashi; Andrew D Reynolds; Melvin L Dillard; Ellen M Carpenter; Matthew P Hoffman
Journal:  Development       Date:  2011-11-24       Impact factor: 6.868

2.  Human breast cancer metastases to the brain display GABAergic properties in the neural niche.

Authors:  Josh Neman; John Termini; Sharon Wilczynski; Nagarajan Vaidehi; Cecilia Choy; Claudia M Kowolik; Hubert Li; Amanda C Hambrecht; Eugene Roberts; Rahul Jandial
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-06       Impact factor: 11.205

Review 3.  Genomic and epigenetic profiles of gastric cancer: potential diagnostic and therapeutic applications.

Authors:  Keishi Yamashita; Shinichi Sakuramoto; Masahiko Watanabe
Journal:  Surg Today       Date:  2010-12-30       Impact factor: 2.549

4.  Loss of reelin expression in breast cancer is epigenetically controlled and associated with poor prognosis.

Authors:  Torsten Stein; Emilio Cosimo; Xinzi Yu; Paul R Smith; Ronald Simon; Lorna Cottrell; Marie-Anne Pringle; Alexandra K Bell; Laura Lattanzio; Guido Sauter; Cristiana Lo Nigro; Timothy Crook; Laura M Machesky; Barry A Gusterson
Journal:  Am J Pathol       Date:  2010-09-16       Impact factor: 4.307

5.  Reelin Deficiency Delays Mammary Tumor Growth and Metastatic Progression.

Authors:  Elvira Khialeeva; Joan W Chou; Denise E Allen; Alec M Chiu; Steven J Bensinger; Ellen M Carpenter
Journal:  J Mammary Gland Biol Neoplasia       Date:  2017-01-26       Impact factor: 2.673

6.  Common chromosome fragile sites in human and murine epithelial cells and FHIT/FRA3B loss-induced global genome instability.

Authors:  Seyed Ali Hosseini; Susan Horton; Joshua C Saldivar; Satoshi Miuma; Martha R Stampfer; Nyla A Heerema; Kay Huebner
Journal:  Genes Chromosomes Cancer       Date:  2013-08-09       Impact factor: 5.006

7.  Molecular inversion probe analysis detects novel copy number alterations in Ewing sarcoma.

Authors:  Mona S Jahromi; Angelica R Putnam; Colleen Druzgal; Jennifer Wright; Holly Spraker-Perlman; Michelle Kinsey; Holly Zhou; Kenneth M Boucher; R Lor Randall; Kevin B Jones; David Lucas; Andrew Rosenberg; Dafydd Thomas; Stephen L Lessnick; Joshua D Schiffman
Journal:  Cancer Genet       Date:  2012 Jul-Aug

Review 8.  Epigenetics: an emerging player in gastric cancer.

Authors:  Changwon Kang; Ji-Joon Song; Jaeok Lee; Mi Young Kim
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

9.  Identification of allelic expression imbalance genes in human hepatocellular carcinoma through massively parallel DNA and RNA sequencing.

Authors:  Qiudao Wang; Yan An; Qing Yuan; Yao Qi; Ying Ou; Junhui Chen; Jian Huang
Journal:  Med Oncol       Date:  2016-03-21       Impact factor: 3.064

Review 10.  The dynamics of DNA methylation in schizophrenia and related psychiatric disorders.

Authors:  Dennis R Grayson; Alessandro Guidotti
Journal:  Neuropsychopharmacology       Date:  2012-09-05       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.